These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 23439459)

  • 1. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
    Nawathe PA; Ravindranath TM; Satwani P; Baird JS
    Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report.
    Ameli F; Ghafourian F; Masir N
    J Med Case Rep; 2014 Aug; 8():288. PubMed ID: 25163591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit.
    Mischler M; Fleming GM; Shanley TP; Madden L; Levine J; Castle V; Filipovich AH; Cornell TT
    Pediatrics; 2007 May; 119(5):e1212-8. PubMed ID: 17403820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment.
    Nair V; Das S; Sharma A; Sharma S; Sharma P; Ray S; Bhattacharya S
    Postgrad Med J; 2013 Apr; 89(1050):185-92. PubMed ID: 23243150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Abe Y; Shiratsuchi M; Nagasawa E; Ohtsuka R; Kiyasu J; Sada E; Idutsu K; Kotoh K; Nishimura J; Ohga S; Takayanagi R
    Rinsho Ketsueki; 2010 Jan; 51(1):74-9. PubMed ID: 20134144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEN-like eruption in setting of EBV positive T-cell lymphoproliferative disease with HLH, in a child.
    Sharma N; Clark J; Pham H; Efron D; MacGregor D; O'Keefe R; Orchard D
    Australas J Dermatol; 2014 Aug; 55(3):e44-7. PubMed ID: 23573996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
    Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
    APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated hyperkeratotic and granulomatous nodules in a child with fatal Epstein-Barr-virus-associated hemophagocytic lymphohistiocytosis.
    Brinkmeier T; Reuter T; Metze D; Frosch PJ; Herbst RA
    Pediatr Dermatol; 2006; 23(1):35-8. PubMed ID: 16445409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients.
    Sonke GS; Ludwig I; van Oosten H; Baars JW; Meijer E; Kater AP; de Jong D
    Clin Infect Dis; 2008 Jul; 47(1):105-8. PubMed ID: 18491961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus.
    Gonzalo DH; Rodriguez G; Marcilla D
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):206-7. PubMed ID: 17356405
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients.
    Elazary AS; Wolf DG; Amir G; Avni B; Rund D; Yehuda DB; Sviri S
    J Clin Virol; 2007 Oct; 40(2):156-9. PubMed ID: 17703994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
    Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
    Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation.
    Albayrak M; Kaya Z; Yilmaz-Keskin E; Stadt UZ; Koçak U; Gürsel T
    Turk J Pediatr; 2009; 51(4):371-4. PubMed ID: 19950846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.
    Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of hemophagocytic lymphohistiocytosis after the primary Epstein-Barr virus infection.
    Kitazawa Y; Saito F; Nomura S; Ishii K; Kadota E
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):323-8. PubMed ID: 17636196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
    Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
    Balamuth NJ; Nichols KE; Paessler M; Teachey DT
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.